Role of hypoxia-inducible factor-1 alpha in the regulation of plasminogen activator activity in rat knee joint chondrocytes

Osteoarthritis and Cartilage

Volumn 17, Issue 11, 2009, Pages 1494-1502

  Zhu, G ^a   Tang, Y ^a   Liang, X ^a   Zheng, M ^a   Yang, J ^a   Zhou, H ^a   Li, L ^a   Qin, T ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Cartilage; Chondrocytes; Hypoxia inducible factor 1 ; Plasminogen activator

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMALL INTERFERING RNA; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARTILAGE CELL; CELL HYPOXIA; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SUBSTRATE; GENE SILENCING; GENE TARGETING; KNEE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; BLOTTING, WESTERN; CARTILAGE, ARTICULAR; CELL HYPOXIA; CELLS, CULTURED; CHONDROCYTES; HYPOXIA-INDUCIBLE FACTOR 1; KNEE JOINT; PLASMINOGEN ACTIVATORS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 70349770724     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2009.05.005     Document Type: Article

References (38)

1. Irigoyen J.P., Munoz-Canoves P., Montero L., Koziczak M., and Nagamine Y. The plasminogen activator system: biology and regulation. Cell Mol Life Sci 56 (1999) 104-132
2. Rosso A.D., Cinelli M., Guiducc S., Pignone A., Fibbi G., Margheri F., et al. Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes. Rheumatology 44 (2005) 1255-1262
3. Slot O., Brunner N., Locht H., Oxholm P., and Stephens R.W. Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis. Ann Rheum Dis 58 (1999) 488-492
4. Kruithof E.K.O., Tran-Thang C., Ransijn A., and Bachmann F. Demonstration of a fast acting inhibitor of plasminogen activators in human plasma. Blood 64 (1984) 907-913
5. Busso N., Peclat V., So A., and Sappino A.P. Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints. Ann Rheum Dis 56 (1997) 550-557
6. Belcher C., Fawthrop F., Bunning R., and Doherty M. Plasminogen activators and their inhibitors in synovial fluids from normal, osteoarthritis, and rheumatoid arthritis knees. Ann Rheum Dis 55 (1996) 230-236
7. Campbell I.K., Piccoli D.S., Roberts M.J., Muirden K.D., and Hamilton J.A. Effects of tumor necrosis factor alpha and beta on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes. Arthritis Rheum 33 (1990) 542-552
8. Oleksyszyn J., and Augustine A.J. Plasminogen modulation of IL-1-stimulated degradation in bovine and human articular cartilage explants. The role of the endogenous inhibitors: PAI-1, alpha(2)-antiplasmin, alpha(1)-PI, alpha(2)-macroglobulin and TIMP. Inflamm Res 45 (1996) 464-472
9. Li J., Ny A., Leonardsson G., Nandakumar K.S., Holmdahl R., and Ny T. The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II induced arthritis. Am J Pathol 166 (2005) 783-792
10. Cook A.D., Braine E.L., Campbell I.K., and Hamilton J.A. Differing roles for urokinase and tissue-type plasminogen activator in collagen induced arthritis. Am J Pathol 160 (2002) 917-926
11. Matsuo O., Tanaka S., and Kikuchi H. Effect of urinary trypsin inhibitor on osteoarthritis. Thromb Res 52 (1988) 237-245
12. Lund-Olesen K. Oxygen tension in synovial fluids. Arthritis Rheum 13 (1970) 769-776
13. O'Hara B.P., Urban J.P., and Maroudas A. Influence of cyclic loading on the nutrition of articular cartilage. Ann Rheum Dis 49 (1990) 536-539
14. Silver I.A. Measurement of pH and ionic composition of pericellular sites. Philos Trans R Soc Lond B Biol Sci 271 (1975) 261-272
15. Rajpurohit R., Koch C.J., Tao Z., Teixeira C.M., and Shapiro I.M. Adaptation of chondrocytes to low oxygen tension: relationship between hypoxia and cellular metabolism. J Cell Physiol 168 (1996) 424-432
16. Pfander D., and Gelse K. Hypoxia and osteoarthritis: how chondrocytes survive hypoxic environments. Curr Opin Rheumatol 19 (2007) 457-462
17. Semenza G.L. Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis. J Lab Clin Med 131 (1998) 207-214
18. Coimbra I.B., Jimenez S.A., Hawkins D.F., Piera-Velazquez S., and Stokes D.G. Hypoxia inducible factor-1 alpha expression in human normal and osteoarthritic chondrocytes. Osteoarthritis Cartilage 12 (2004) 336-345
19. Kietzmann T., Roth U., and Jungermann K. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 94 (1999) 4177-4185
20. Bechtel M.J., Reinartz J., Rox J.M., Inndorf S., Schaefer B.M., and Kramer M.D. Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1β and tumor necrosis factor-α. Exp Cell Res 223 (1996) 395-404
21. Chung H.W., Wen Y., Ahn J.J., Moon H.S., and Polan M.L. Interleukin-1 beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells. J Clin Endocrinol Metab 86 (2001) 1332-1340
22. Yudoh K., Nakamura H., Masuko-Hongo K., Kato T., and Nishioka K. Catabolic stress induces expression of hypoxia-inducible factor (HIF)-1α in articular chondrocytes: involvement of HIF-1α in the pathogenesis of osteoarthritis. Arthritis Res Ther 7 (2005) R904-R914
23. Tsukazaki T., Usa T., Matsumoto T., Enomoto H., Ohtsuru A., Namba H., et al. Effect of transforming growth factor-β on the insulin-like growth factor-I autocrine/paracrine axis in cultured rat articular chondrocytes. Exp Cell Res 215 (1994) 9-16
24. Brucker P.U., Izzo N.J., and Chu C.R. Tonic activation of hypoxia-inducible factor 1alpha in avascular articular cartilage and implications for metabolic homeostasis. Arthritis Rheum 52 (2005) 3181-3191
25. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
26. Sadowski T., and Steinmeyer J. Differential effects of nonsteroidal antiinflammatory drugs on the IL-1 altered expression of plasminogen activators and plasminogen activator inhibitor-1 by articular chondrocytes. Inflamm Res 51 (2002) 427-433
27. Schipani E., Ryan H.E., Didrickson S., Kobayashi T., Knight M., and Johnson R.S. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 15 (2001) 2865-2876
28. Pfander D., Cramer T., Schipani E., and Johnson R.S. HIF-1α controls extracellular matrix synthesis by epiphyseal chondrocytes. J Cell Sci 116 (2003) 1819-1826
29. Stewart A.J., Houston B., and Farquharson C. Elevated expression of hypoxia inducible factor-2α in terminally differentiating growth plate chondrocytes. J Cell Physiol 206 (2006) 435-440
30. Lafont J.E., Talma S., and Murphy C.L. Hypoxia-inducible factor 2α is essential for hypoxic induction of the human articular chondrocyte phenotype. Arthritis Rheum 56 (2007) 3297-3306
31. Meade E.S., Ma Y.Y., and Guller S. Role of hypoxia-inducible transcription factors 1α and 2α in the regulation of plasminogen activator inhibitor-1 expression in a human trophoblast cell line. Placenta 28 (2007) 1012-1019
32. Carroll V.A., and Ashcroft M. Role of hypoxia-inducible factor (HIF)-1α versus HIF-2α in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Cancer Res 66 (2006) 6264-6270
33. Blasi F., and Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 3 (2002) 932-943
34. Preissner K.T., Kanse S.M., and May A.E. Urokinase receptor: a molecular organizer in cellular communication. Curr Opin Cell Biol 12 (2000) 621-628
35. Graham C.H., Fitzpatrick T.E., and McCrae K.R. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. Blood 91 (1998) 3300-3307
36. Kroon M.E., Koolwijk P., van der Vecht B., and van Hinsbergh V.W. Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix. Blood 96 (2000) 2775-2783
37. Kroon M.E., Koolwijk P., van Goor H., Weidle U.H., Collen A., van der Pluijm G., et al. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices. Am J Pathol 154 (1999) 1731-1742
38. Dong J., Fujii S., Imagawa S., Matsumoto S., Matsushita M., Todo S., et al. IL-1 and IL-6 induce hepatocyte plasminogen activator inhibitor-1 expression through independent signaling pathways converging on C/EBPδ. Am J Physiol Cell Physiol 292 (2007) C209-C215